Clinical Trial Update: Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy [Phase 1]

View source ↗

Summary

A Phase 1 study of RLS103 in a clinical model of photosensitive epilepsy was terminated; the trial aimed to evaluate safety, tolerability, and preliminary effic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Photosensitive Epilepsy

Drugs mentioned

• RLS103

Snippet

Sponsor: Receptor Life Sciences | Conditions: Epilepsy | Phase 1 | Status: TERMINATED